>
Florida Sues Pfizer, Accusing It of Covid Vaccine Deception and Profiteering
The State as an Extension of Self: Psychological Evil
Yemen Has Not Even Started Yet
The Irresistible Appeal of Anarchism
Med Beds Just Took a MASSIVE Step Forward, Healing People in Days!
Palmer Luckey: Autonomous Weapons Are Ancient and Why Anduril Won't Build Humanoids | EP #295
A laser just photographed objects through six feet of concrete
Elon Musk's Next-Gen Motor Destroy Entire EV Industry
China's disputed satellite refueling heralds new space war era
BYD Will Put Solid-State Batteries In An EV Next Year: Executive
FDA-cleared exoskeleton puts spinal-cord patients back on their feet
Your Robotic Vacuum Is Watching You -- Could It Someday Testify Against You in Court?
Why Unigrid's Sodium-Ion Batteries Are the Game-Changer for Off-Grid Energy Storage
This Battery On Wheels Makes Any Diesel Truck Electric In 5 Minutes

An ancient Greek drug derived from the saffron plant could improve the treatment of people with severe COVID-19 and reduce the COVID mortality rate by as much as 50%, according to a report published earlier this month in the European Journal of Internal Medicine by an Israeli researcher from the Hebrew University of Jerusalem and Hadassah Medical School.
The drug, colchicine, dates back thousands of years to ancient Egypt, where it was known for its special healing properties. It is one of a few medicines that survived until modern times. Most recently, it has been used to treat and prevent inflammation caused by gout that can lead to painful arthritis and Familial Mediterranean Fever (FMF), which is common among Jewish people of North African descent.